Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DrBrainRx vs Eve

DrBrainRx
Graded #104

Higher grade

vs+4.799999999999997
Eve
Graded #210

Lower grade

The verdict

DrBrainRx takes it — 70.8/100 to 66/100.

DrBrainRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrBrainRx is a neurologist-founded telehealth clinic led by Dr.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDrBrainRx +12
66
54
Dose & formulationEve +16
72
88
Clinical oversightDrBrainRx +8
87
79
Labs & monitoringDrBrainRx +12
64
52
FulfillmentEven
67
67
Contract termsDrBrainRx +20
61
41
DrBrainRx · left barEve · right bar

The numbers

MetricDrBrainRxEve
WeighScore70.8/10066/100
GradeCC
Scorecard rank#104#210
Semaglutide$199/mo (all doses, compounded)$195/mo (compounded)
Tirzepatide$299/mo (all doses, compounded)$195/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
DrBrainRx

Graded #104 · C

Strengths

  • Founded and overseen by Dr. Sara Siavoshi — triple board-certified in Neurology, Headache Medicine, and Obesity Medicine
  • LegitScript certified with compounded medications from USP-certified 503B pharmacies
  • Flat-rate pricing — same monthly cost for all dose levels (dose escalation does not raise price)
  • 100% online with rapid approvals (~24-48 hours) and discreet shipping in 3–5 business days
  • Side-effect support, dose adjustments, and injection guides included with provider care

Where it loses points

  • Separate $25/month provider care fee (compounded track) on top of medication cost
  • Compounded medications are not FDA-approved individual drugs
  • Labs not required or included — no baseline bloodwork protocol disclosed
  • States served not published; no explicit list available
  • No dedicated coaching program beyond clinical dose management
Eve

Graded #210 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard